iHuman Inc.: Form 20-F for the period ended Dec 31, 2025
Filed with the SEC on Apr 24, 2026 and accepted by EDGAR at Apr 24, 2026, 16:02 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2025-01-01 to 2025-12-31 | $115.4m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2025-01-01 to 2025-12-31 | $37.1m | us-gaap:CostOfRevenue |
| Gross profit | 12 months2025-01-01 to 2025-12-31 | $78.3m | us-gaap:GrossProfit |
| Research and development | 12 months2025-01-01 to 2025-12-31 | $29.8m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2025-01-01 to 2025-12-31 | $9.5m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2025-01-01 to 2025-12-31 | $913.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2025-01-01 to 2025-12-31 | $13.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2025-01-01 to 2025-12-31 | $0.05 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2025-01-01 to 2025-12-31 | $0.05 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2025-01-01 to 2025-12-31 | 267,614,972 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2025-01-01 to 2025-12-31 | $7.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2025-01-01 to 2025-12-31 | $701.0k | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 12 months2025-01-01 to 2025-12-31 | $5.6m | us-gaap:PaymentsOfDividends |
| Share repurchases | 12 months2025-01-01 to 2025-12-31 | $2.5m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2025-12-31 | $164.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-12-31 | $185.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2025-12-31 | $195.7m | us-gaap:Assets |
| Current liabilities | At period end2025-12-31 | $52.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-12-31 | $53.4m | us-gaap:Liabilities |
| Shareholders' equity | At period end2025-12-31 | $142.3m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001104659-26-048541. Last ingested by Listed: Oct 24, 2026, 15:06 ET. Listed shows no prices and gives no investment advice.